Browsing byAuthorGulati, N
Showing results 1 to 8 of 8
| Issue Date | Title | Author(s) |
| 2022-01-01 | Advanced drug delivery systems for targeting obesity | Gulati, N; Dua, K; Dureja, H |
| - | Advances in nano-based drug delivery systems for the management of cytokine influx-mediated inflammation in lung diseases | Gulati, N; Chellappan, DK; MacLoughlin, R; Gupta, G; Singh, SK; Oliver, BG; Dua, K; Dureja, H |
| 2022-05-08 | Enhancing the Therapeutic Potential of Nanomedicines by Modifying Surface Characteristics. | Gulati, N; Dua, K; Dureja, H |
| 2021-09 | Inhaled nano-based therapeutics for inflammatory lung diseases: Recent advances and future prospects | Gulati, N; Chellappan, DK; MacLoughlin, R; Dua, K; Dureja, H |
| 2024 | Monoclonal antibodies and antibody-drug conjugates as emerging therapeutics for breast cancer treatment. | Saini, S; Gulati, N; Awasthi, R; Arora, V; Singh, S; Kumar, S; Gupta, G; Dua, K; Pahwa, R; Dureja, H |
| 2021-05 | Oral Nanoemulsion of Fenofibrate: Formulation, Characterization, and In Vitro Drug Release Studies. | Gulati, N; Kumar Chellappan, D; Tambuwala, M; A A Aljabali, A; Prasher, P; Kumar Singh, S; Anand, K; Sharma, A; Kumar Jha, N; Gupta, G; Dua, K; Dureja, H |
| 2024-03-05 | Recent Trends and Applications of Nanostructure-based Drug Delivery in Alleviating Chronic Obstructive Pulmonary Disease (COPD) | Lokesh,; Gulati, N; Saini, A; Singh, S; Gupta, G; MacLoughlin, R; Chellappan, DK; Dua, K; Dureja, H |
| 2021-06-08 | Role of chitosan based nanomedicines in the treatment of chronic respiratory diseases. | Gulati, N; Dua, K; Dureja, H |
